Introduction
In 2002, Clarke et al published data describing mortality rates of 40% for trauma patients requiring laparotomy who arrived hypotensive with a systolic blood pressure (SBP) less than 90 mm Hg.1 Since the publication of that study, numerous advancements in the care of hypotensive trauma patients have occurred, including further advancements in damage control laparotomy, balanced resuscitation, massive transfusion protocols, bedside ultrasonography, angioembolization, correction of coagulopathy and, most recently, the widespread implementation of resuscitative endovascular balloon occlusion of the aorta (REBOA).2–6 In light of these changes, Harvin et al conducted a similar study at ten level I trauma centers across the USA in 2017 to investigate whether mortality had changed in 15 years.2 Surprisingly, the results revealed an essentially unchanged mortality rate of 46% for the hypotensive patient population, with two-thirds of these deaths attributed to hemorrhage. A similar study of mortality with laparotomy for hypotensive trauma patients performed in the UK in 2018 showed a 48% mortality rate for civilian trauma.7
However, hypotension is not a binary variable (less than or greater than 90 mm Hg), and the mortality for hypotensive trauma patients requiring laparotomy is likely more nuanced than a single threshold number. REBOA has recently been incorporated into some trauma resuscitation protocols. One such protocol recommends consideration of REBOA for patients arriving with SBP of <90 mm Hg who are transient or non-responders to initial crystalloid resuscitation.6 These algorithms have been proposed primarily based on comparison data with emergency department (ED) thoracotomy and have not been otherwise validated.8 9
The use of REBOA is not without risks. Major complications including injury to femoral vessels, arterial thrombus/embolus, limb loss, need for fasciotomy, balloon rupture, and mesenteric ischemia with prolonged deployment have all been reported.10 11 Brenner et al published the largest single-center experience with REBOA use and found significant complications in 29%.12 Joseph et al reported a greater rate of acute kidney injury and increased lower extremity amputation and mortality in patients with REBOA usage versus a matched cohort without REBOA in a study of the American College of Surgeons Trauma Quality Improvement (TQIP) database.13
The purpose of this study was to determine the mortality rate for hypotensive patients requiring laparotomy in a level I trauma center and to evaluate mortality risk related to degree of hypotension. Additionally, this study sought to determine if there was a presenting SBP that was associated with a sharp increase in mortality to target the appropriate patient group most likely to benefit from focused interventions such as REBOA.